CMR Surgical’s Versius Plus robot’s clearance follows the FDA’s de novo classification of the company’s first-generation ...

CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System in October 2024.

As competition intensifies among surgical robot makers, CMR said its soft tissue platforms are the second most used systems ...

Medtronic and CMR Surgical got the FDA’s green light this month, while SS Innovations applied for clearance. Catch up on the ...

CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius Plus, has received 510 (k) clearance from the United States Food and Drug ...

CMR Surgical is launching a new imaging technology to help users of its Versius robot visualize the flow of blood through organs during a procedure. The company’s vLimeLite add-on incorporates a ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare ...